Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation

The key metabolic sensor adenosine monophosphate-dependent kinase (AMPK) has emerged as a promising therapeutic target for cancer prevention and treatment. Besides its role in energy homeostasis, AMPK blocks cell cycle, regulates autophagy and suppresses the anabolic processes required for rapid cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Bort, Alicia, Quesada, Sergio, Ramos-Torres, Ágata, Gargantilla, Marta, Priego, Eva María, Raynal, Sophie, Lepifre, Franck, Gasalla, Jose M., Rodriguez-Henche, Nieves, Castro, Ana, Díaz-Laviada, Inés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847527/
https://www.ncbi.nlm.nih.gov/pubmed/29531259
http://dx.doi.org/10.1038/s41598-018-22690-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847527/
https://www.ncbi.nlm.nih.gov/pubmed/29531259
http://dx.doi.org/10.1038/s41598-018-22690-2

Ejemplares similares